The University of Utah Health Emergency Department is a fully approved Level 1 Trauma facility and tertiary referral center that is staffed by physicians 24 hours a day, 7 days a week. The department has a census of about 50,000 patient visits annually and provides excellent care for acute emergencies in all subspecialties of medicine and surgery. Patients from all over Utah, Nevada, Wyoming, Idaho and western Colorado are referred to the emergency department for definitive medical care.
All full-time faculty in the division are trained in emergency medicine and certified by the American Board of Emergency Medicine. Attending faculty are on duty 24 hours a day and are directly involved in the clinical training of housestaff and medical students. Academic faculty in the division are active in ongoing clinical trials and research at the University. The division also has a Clinical Toxicology Consult Service. Other specialties within the division include Emergency Medical Ambulance Services and Disaster Medicine. The Division of Emergency Medicine also runs the AirMed Patient Transport Service.
University of Utah Health and the Salt Lake City Fire Department have partnered to train the next generation of physicians by initiating a physician scene response program, the first of its kind in the state. ... Read More
Nicholas Levin, MD won the American College of Emergency Physicians 2019 Best Resident Research Paper Award. Highly deserved! Congratulations! The study was titled, "The Use of delta-Modified Early Warning Scores Predicts Additional Mortality Risk Within qSOFA-Negative Emergency Department Patients."
https://www.acep.org/rf/... Read More
No matter how old you are, you can make a difference during the coronavirus pandemic by staying home to slow the spread of the coronavirus disease 2019 (COVID-19). In the face of a global pandemic, that simple act can save lives.
... Read More
Tranexamic acid (TXA) improves survival in traumatic hemorrhage, but difficulty obtaining intravenous (IV) access may limit its use in austere environments, given its incompatibility with blood products. The bioavailability of intramuscular (IM) TXA in a shock state is unknown. We hypothesized that IM and IV administration have similar pharmacokinetics and ability to reverse in vitro hyperfibrinolysis in a swine controlled-hemorrhage model.... Read More
On May 16 2007, Dr. Scott McIntosh reached the summit of Mt. Everest with an all Sherpa team. This team included record-holder Apa Sherpa who had summitted for the 17th time, and the speed record-holder Lhakpa Sherpa who raced from Base Camp to the Summit in under 11 hours. Along the way, Dr. McIntosh performed physiological tests on the Sherpas to help elucidate how and why the Sherpas function so well at high altitude. He has published research on Sherpa physiology as well as lectured widely on the subject.... Read More